Department of Clinical Laboratory Medicine and Division of Diagnostic Pathology, Shiga University of Medical Science, Japan.
J Eur Acad Dermatol Venereol. 2013 Jan;27(1):e128-30. doi: 10.1111/j.1468-3083.2011.04436.x. Epub 2012 Jan 5.
Cathepsin K is a cysteine protease with strong collagenolytic and elastolytic properties. Recently, cathepsin K expression in tumour cells of malignant melanoma and in the stromal cells of squamous cell carcinoma of the skin has been reported to play an important role in tumour progression. However, its expression profile in basal cell carcinoma (BCC) has not yet been clarified.
The aim of this study is to examine the expression profile of cathepsin K in both the tumour cells and the peritumoural stromal cells of BCC in comparison with its expression in normal skin.
Fifty consecutive operative cases of BCC, 10 cases of actinic keratosis, 10 cases of Bowen's disease and five normal skin tissues were assessed for cathepsin K expression by immunohistochemical methods.
In normal skin, cathepsin K expression was observed in the stratum corneum, mature sebaceous cells and outer root sheath of the hair follicles. Cathepsin K was expressed in the tumour cells of all BCC cases, in which 90% showed diffuse expression (>51% of tumour cells), as well as in the peritumoural stromal cells in all BCC cases. Focal cathepsin K expression was observed in the tumour cells of Bowen's disease (2/10 cases), but not in any of actinic keratosis (0/10 cases).
Cathepsin K expression may contribute to tumour invasion and peculiar histopathological features, such as fibromucinous stroma around the tumour nests by mediating extracellular matrix degradation in BCC.
组织蛋白酶 K 是一种半胱氨酸蛋白酶,具有很强的胶原分解和弹性蛋白酶活性。最近,有研究报道恶性黑色素瘤肿瘤细胞和皮肤鳞状细胞癌基质细胞中的组织蛋白酶 K 表达在肿瘤进展中发挥重要作用。然而,其在基底细胞癌(BCC)中的表达谱尚未阐明。
本研究旨在比较 BCC 肿瘤细胞和肿瘤周围基质细胞中组织蛋白酶 K 的表达谱与正常皮肤中的表达情况。
采用免疫组织化学方法检测 50 例连续手术的 BCC 病例、10 例光化性角化病、10 例 Bowen 病和 5 例正常皮肤组织中组织蛋白酶 K 的表达情况。
在正常皮肤中,组织蛋白酶 K 表达于角质层、成熟的皮脂腺细胞和毛囊外根鞘。所有 BCC 病例的肿瘤细胞均表达组织蛋白酶 K,其中 90%呈弥漫性表达(>51%的肿瘤细胞),所有 BCC 病例的肿瘤周围基质细胞也均表达组织蛋白酶 K。Bowen 病的肿瘤细胞中观察到组织蛋白酶 K 的局灶性表达(10 例中的 2 例),但光化性角化病(10 例中无 1 例)中无此表达。
组织蛋白酶 K 的表达可能通过介导细胞外基质的降解,促进 BCC 的肿瘤侵袭和独特的组织病理学特征,如肿瘤巢周围的纤维黏液基质。